Mechanisms of the development of androgen independence in prostate cancer. - Wikidata - awgldk - TriplyDB

Mechanisms of the development of androgen independence in prostate cancer.

Mechanisms of the development of androgen independence in prostate cancer.

http://www.wikidata.org/entity/Q36072079

about

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer The emerging importance of group II PAKs A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression Oncolytic adenovirus-mediated therapy for prostate cancer Prostate cancer relevant antigens and enzymes for targeted drug delivery Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence Efficacy of c-Met inhibitor for advanced prostate cancer.The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo.Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer.PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells.Emerging biological observations in prostate cancer.IGF-I, insulin and prostate cancer.Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.Abiraterone acetate for castration resistant prostate cancer.Cholesterol as a potential target for castration-resistant prostate cancer.Cabazitaxel for the treatment of prostate cancer.Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody.Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential.Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription.Action mechanism and signal pathways of Psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells.

P2860

Q21202034-9133469F-D0B5-47C7-878C-8062353A9879 Q24294885-FAD2C731-54AF-4741-86D5-4A0CA98733A2 Q24336995-6BB3453B-3448-4242-B264-8E860618FB4B Q27004796-834A93EA-BC25-40E8-AF7D-2D372E0603A0 Q27013843-CEFC3965-6999-4C86-A1C3-B01F5A904EC7 Q28278828-F7D534FB-4E3F-464D-A704-4DDF22838C5D Q28477138-6C4A0F02-C475-428C-BFFF-633C2321837E Q28547789-16F0CC80-0FFA-4196-A4CE-CBA64B134411 Q33579568-3E75760F-52B4-40B7-9F6D-13C50EB4C2CA Q33718726-8DE96B0D-CC77-4585-A5DF-89FE01F7DA60 Q33976977-F48872F8-9266-408A-8233-0CC760D737C5 Q34383988-7CEF0485-4FEA-4F8A-AEC1-C63CCC709F9F Q34786431-36DDDA5E-C879-4FDF-AF8E-B335B227B7AE Q34999154-DB707BD1-D61C-4EFA-95DC-E9E2386F7489 Q35146525-0CD2DA99-7F85-4578-833D-DABC91C1613E Q35597031-8A229EF3-BC32-4645-9D78-5309B3D07682 Q35882782-CB00C6EF-4D65-4520-9DBD-F416B354863D Q36002634-A572C5B6-0E28-478F-9618-38A3B7C791B1 Q36381291-D40B8175-F839-422B-B691-A63D61E2CA0D Q36435787-15E027F2-D0D2-4AD5-B9C7-D0C97C152149 Q36458374-48CF1596-51EF-48D7-B470-2098A5F21FF9 Q36567984-B194BC5D-604F-482F-A115-B07436936C27 Q36734036-08C36697-B2A2-4660-ACEF-49F5E84AEB5B Q37120640-1BFB89CC-7A9A-4C91-A769-B8257FDB03CC Q37424118-E3049633-EC2B-48A1-A277-B949CF32A8CB Q37656229-4F3E09E6-9FA8-40C0-B60D-5939F3268116 Q37686154-6862011C-FF62-4D6F-B2B3-C10CD167F3FD Q37694029-5A0C7306-6EBA-4623-A88A-8AE47997E27F Q37708308-D8A84BAC-93B9-4E5B-B91F-7E5D68AD6BE8 Q37777663-1F5093DE-8CD4-499F-B288-45B6C72FEF00 Q37853193-9918A142-DDFC-48EE-894A-EA24A4D81F3B Q38554434-3D43EAC6-A484-455A-84C7-DB02FB964BEC Q39016653-DA4A349B-8DE6-4DF8-97FF-EAFC2FF4056F Q39045060-BD14DBD9-F120-4B34-B0E9-EE791BA984F6 Q39219294-F04D9B74-2C4C-476C-AC45-C5551846F9EF Q39260494-6070603B-8B0C-434F-9916-59695EC40A05 Q39398599-F58081F5-904F-4D89-9975-060C16F6AE26 Q39456241-9A25F4B6-198A-401B-9244-B7FEC2496FE1 Q39738255-095D238D-62C7-4B8C-AC6B-0A33F2E3CBDC Q39748389-BF20472E-E76F-48FD-A8C7-12846BFDCA2A

P2860

Mechanisms of the development of androgen independence in prostate cancer.

http://www.wikidata.org/entity/Q36072079

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Mechanisms of the development of androgen independence in prostate cancer.

@ast

Mechanisms of the development of androgen independence in prostate cancer.

@en

type

label

Mechanisms of the development of androgen independence in prostate cancer.

@ast

Mechanisms of the development of androgen independence in prostate cancer.

@en

prefLabel

Mechanisms of the development of androgen independence in prostate cancer.

@ast

Mechanisms of the development of androgen independence in prostate cancer.

@en

P1433

Q36072079-4A16D504-7570-4710-A1EE-2773B0D6CD36

P1476

Q36072079-D2C5ACBC-06C7-4AD6-8D46-41709136FAFD

P2093

Q36072079-5F6977A4-34F5-4D13-8CEE-092025B0149C

Q36072079-664E53C5-A445-478F-9B1C-5E325612A3D8

Q36072079-83E526CC-05FC-4F8F-9874-D0F957F7A12F

Q36072079-AA82F482-82CF-4913-9DFA-577B007FBF58

P2860

Q36072079-A10C82AB-CB59-48FF-9841-5CF8D90DFA9E

P2888

Q36072079-877E4E4C-A90F-4B64-AF22-D50DC673AAD2

P304

Q36072079-C78DD6C4-7440-4AD5-81AB-AD6A4FE42A4E

P31

Q36072079-AEC5109F-EE32-4523-9729-5AC0B8FC1FDF

P356

Q36072079-ACD020D4-6C85-4915-8CA5-7158A62CAAB4

P433

Q36072079-1011F83E-9207-49E2-8E1A-5AC678F92A6D

P478

Q36072079-0EAAEF47-50F4-4005-A78B-70BF414B74B2

P577

Q36072079-E77CB3BF-3B26-47D3-8288-B74539891D4F

P698

Q36072079-D8B99010-7893-4762-A1C6-367C9B98AB60

P356

S00345-004-0473-1

P1433

World Journal of Urology

P1476

Mechanisms of the development of androgen independence in prostate cancer.

@en

P2093

Alan So

http://www.w3.org/2001/XMLSchema#string

Antonio Hurtado-Col

http://www.w3.org/2001/XMLSchema#string

Colleen Nelson

http://www.w3.org/2001/XMLSchema#string

Martin Gleave

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

P2888

s00345-004-0473-1

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00345-004-0473-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15770516

http://www.w3.org/2001/XMLSchema#string